EGFR and esophageal squamous cell carcinoma: In our recent study, we made diagnostic and therapeutic convergence radiopharmaceutical, 64Cu-/177Lu-cetuximab for imaging and therapy in EGFR expressing esophageal squamous cell carcinoma (ESCC) model [25].